04/22/2024
11:15 PM | Mateon Therapeutics (Filer)
Oncotelic Therapeutics, Inc. (Filer)
| Form EFFECT | |
04/18/2024
4:25 PM | Mateon Therapeutics (Filer)
Oncotelic Therapeutics, Inc. (Filer)
| Form POS AM | |
04/12/2024
4:00 PM | Mateon Therapeutics (Filer)
Oncotelic Therapeutics, Inc. (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
04/12/2024
4:15 PM | Mateon Therapeutics (Filer)
Oncotelic Therapeutics, Inc. (Filer)
| Form POS AM | |
02/02/2024
4:00 PM | Mateon Therapeutics (Filer)
Oncotelic Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/30/2023
8:00 AM | Mateon Therapeutics (Filer)
Oncotelic Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/23/2023
9:30 AM | Mateon Therapeutics (Filer)
Oncotelic Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/18/2023
4:00 PM | Mateon Therapeutics (Filer)
Oncotelic Therapeutics, Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/13/2023
8:25 AM | Mateon Therapeutics (Filer)
Oncotelic Therapeutics, Inc. (Filer)
| Form D
Notice of Exempt Offering of Securities | |
07/13/2023
8:15 AM | Mateon Therapeutics (Filer)
Oncotelic Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/30/2023
8:25 AM | Mateon Therapeutics (Issuer)
Oncotelic Therapeutics, Inc. (Issuer)
Trieu Vuong (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2023
11:00 AM | Mateon Therapeutics (Issuer)
Oncotelic Therapeutics, Inc. (Issuer)
Trieu Vuong (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2023
11:00 AM | Mateon Therapeutics (Issuer)
Oncotelic Therapeutics, Inc. (Issuer)
Trieu Vuong (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2023
8:39 AM | Mateon Therapeutics (Issuer)
Oncotelic Therapeutics, Inc. (Issuer)
Trieu Vuong (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2023
8:11 PM | Mateon Therapeutics (Filer)
Oncotelic Therapeutics, Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/19/2023
3:45 PM | Mateon Therapeutics (Filer)
Oncotelic Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/25/2023
11:15 PM | Mateon Therapeutics (Filer)
Oncotelic Therapeutics, Inc. (Filer)
| Form EFFECT | |
